A method to simultaneously measure oxygenation in vascular, intracellular, and mitochondrial spaces from optical spectra acquired from muscle has been developed. In order to validate the method, optical spectra in the visible and near-infrared regions (600-850 nm) were acquired from solutions of myoglobin, hemoglobin, and cytochrome oxidase that included Intralipid as a light scatterer. Spectra were also acquired from the rabbit forelimb. Three partial least squares (PLS) analyses were performed on second-derivative spectra, each separately calibrated to myoglobin oxygen saturation, hemoglobin oxygen saturation, or cytochrome aa3 oxidation. The three variables were measured from in vitro and in vivo spectra that contained all three chromophores. In the in vitro studies, measured values of myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation had standard errors of 5.9%, 7.4%, and 12.2%, respectively, with little cross-talk between the in vitro measurements. In the progression from normal oxygenation to ischemia in the rabbit forelimb, hemoglobin desaturated first, followed by myoglobin, while cytochrome aa3 reduction occurred last. The ability to simultaneously measure oxygenations in the vascular, intracellular, and mitochondrial compartments will be valuable in physiological studies of muscle metabolism and in clinical studies when oxygen supply or utilization are compromised.
INTRODUCTION
Many investigators have used optical spectroscopy to measure tissue oxygenation and cytochrome redox states. The harmless non-ionizing radiation from light and the relatively inexpensive instrumentation make noninvasive optical measurements attractive for basic studies in physiology and pathology, as well as for clinical use. Currently, pulse oximetry, which measures hemoglobin saturation in arterial blood, is commonly used in the hospital setting to evaluate oxygen sufficiency. If oxygenation in the local vascular, intracellular, and mitochondrial spaces could also be known, further refinements to assess efficacies of therapies would be possible in a variety of pathologies. This is especially important in diseases where oxygen supply and/or utilization are compromised, as in shock, peripheral vascular disease, or anemia.
The main chromophores in optical spectra of muscle are hemoglobin, myoglobin, and the cytochromes, each located in a separate anatomical compartment (Fig. 1) . The hemoglobin signal reflects the oxygenation of blood in the local vasculature and is a weighted average of arterial, capillary, and venous blood. Myoglobin is an intracellular protein in muscle cells that facilitates the diffusion of oxygen from the cell membrane to the mitochondria. 1 Both myoglobin and hemoglobin have oxygen-bound and -unbound states that are spectroscopically distinct. In the mitochondria, cytochrome oxidase is the terminal enzyme in the electron transport chain that catalyzes the reaction in which oxygen is reduced to water. As electrons travel down the transport chain, protons are pumped across the inner mitochondrial membrane. Energy stored in this electrochemical gradient is used to make ATP from ADP. Cytochrome oxidase has visible absorbances sensitive to the redox states of hemes aþa3 at ;605 nm and heme a3/Cu B at 655 nm. It also has an absorbance peak in the near-infrared (NIR) region that is sensitive to the redox state of its copper (Cu A ) center at ;830 nm.
Most of the previous optical spectroscopic studies on muscle oxygenation have made measurements at 2, 4, or 6 wavelengths. With so few wavelengths, contributions from hemoglobin and myoglobin cannot be separated because their absorbance spectra are so similar. [2] [3] [4] [5] There remains significant controversy as to whether 2-or 4-wavelength spectroscopy indicates only hemoglobin saturation 2, 3 or whether myoglobin saturation contributes significantly to the measured signal. 5, 6 Other studies have used a 2-, 4-, or 6-wavelength methodology to yield relative changes in cytochrome oxidase redox states in hemoglobin-free perfused muscle 7, 8 or in the brain, in the presence of hemoglobin. 4, [9] [10] [11] Recently, studies that analyze a full spectrum have used linear regression to quantify hemoglobin saturation and concentration, as well as cytochrome oxidase redox states in the brain. 12, 13 Our laboratory has used an approach called partial least squares (PLS) analysis to quantify myoglobin and hemoglobin saturations in cardiac [14] [15] [16] and skeletal muscle [17] [18] [19] from spectra acquired in the visible and NIR regions. We have also shown that cytochrome c oxidation can be determined in the visible region in buffer-perfused hearts. 20 In the present paper, we have extended these analyses to include the measurement of cytochrome aa3 oxidation states in vivo. The method is sensitive to the oxidation state of heme aþa3 of cytochrome oxidase, with an absorbance peak in the 600-630 nm range. Since the contributions of each heme to the spectra cannot be separated, the variable ''cytochrome aa3 oxidation'' reflects a global measurement of the redox state of both hemes.
There are other absorbances attributable to cytochrome oxidase and cytochrome c in the wavelength range that we are using (600-850 nm), but these are not likely to influence the measurement of cytochrome aa3 oxidation. The PLS analysis is trained on spectral variations due to the redox state of heme aþa3 alone so that effects of variations in the spectra from other chromophores (cytochrome c, cytochrome oxidase a3/ Cu B and Cu A , hemoglobin, and myoglobin) are minimized. The molar extinction coefficient of the Cu A absorbance at 830 nm is about 5% of the heme aþa3 extinction coefficient at 605 nm, 21 and the heme a3/Cu B absorbance at 655 nm is small in relation to the 605 nm absorbance (Fig. 2) . PLS measurement of cytochrome aa3 oxidation will be dominated by the heme aþa3 absorbance, which is small in relation to myoglobin and hemoglobin absorbances in vivo, since cytochrome oxidase concentrations are an order of magnitude smaller than hemoglobin and myoglobin.
Problems encountered by any continuous-wave method include unknown scattering coefficients and optical path lengths, the significant overlap of absorbances from different chromophores present in tissue, and the relatively low concentrations of cytochromes relative to myoglobin and hemoglobin. The goal of the present study was to assess how well PLS could overcome these difficulties to quantify hemoglobin saturation, myoglobin saturation, and cytochrome aa3 oxidation simultaneously in blood-perfused skeletal muscle. Calibrations and tests of accuracy in the saturation and oxidation measurements were done in vitro using myoglobin, hemoglobin, and cytochrome oxidase solutions with Intralipid as a light scatterer. Subsequently, measurements were acquired in vivo in the rabbit forelimb.
METHODS
In Vitro Solution Preparation. Lyophilized myoglobin (M-1882, Sigma Chemical) was dissolved in 50 mM phosphate buffer at pH 7.4 to form oxidized metmyoglobin. In order to reduce metmyoglobin to the physiologically active state, excess sodium dithionite was added to the solution that was then separated on a 25-cm Sephadex chromatography column (G-25-150, Sigma Chemical) at 4 8C. Myoglobin solutions were equilibrated with room air to form oxymyoglobin (MbO 2 ), which was further diluted with phosphate buffer to a final concentration of 150 lM. Distinct solutions of identical myoglobin concentrations were made with Intralipid concentrations of 2% and 3%, such that the scattering level varied around that found in tissue. Deoxymyoglobin (Mb) was formed by addition of excess sodium dithionite.
Fresh sheep red blood cells were lysed by dilution with distilled water and added to Intralipid-containing solutions as above. Final solutions of 50 and 100 lM hemoglobin, covering the range of hemoglobin found in skeletal muscle, 22, 23 were used. Solutions were gently bubbled with oxygen to make oxyhemoglobin (HbO 2 ). A solution at each hemoglobin concentration was combined separately with 2% and 3% Intralipid concentrations. Deoxyhemoglobin (Hb) was made by addition of excess sodium dithionite.
Cytochrome oxidase was purified from beef heart using the method of Yonetani. 24 Cytochrome oxidase was then diluted in buffer containing Intralipid at concentrations of 2% and 3%. Oxidized (cyt aa3 ox ) and reduced (cyt aa3 red ) forms were prepared by addition of potassium ferricyanide and sodium dithionite, respectively. Each solution had a final concentration of approximately 6.5 lM. Rabbit Forelimb Measurements. All experiments were performed in accordance with the University of Washington Animal Care Committee regulations. Two New Zealand White rabbits (mean weight 2.4 kg) were anesthetized with an initial dose of ketamine (35 mg/kg) and xylazine (5 mg/kg) delivered intramuscularly to the femoral region. The neck was shaved before a tracheostomy was performed. The animals were mechanically ventilated at 24 breaths/min (model 708, Harvard Apparatus) on 100% oxygen. A 1.5-Fr microtip catheter transducer (model SPR 612, Millar Instruments) was inserted into the carotid artery to monitor blood pressure. Supplemental doses of ketamine were administered at 30-min intervals. Blood gases from samples taken from the carotid artery were measured using an I-Stat analyzer (cartridge EC4, Abbott Laboratories). Ventilation rate was adjusted and bicarbonate was administered to maintain physiological blood gas values.
After shaving the forelimb, the biceps brachii muscle was exposed by opening the skin, and the optical probe was placed directly on the muscle. By visual inspection, the optical probe was not placed over a large vein or artery, so that the hemoglobin signal presumably arose primarily from arterioles, capillaries, and venules. Silver barbed wires (25 gauge) were placed near the origin and insertion of the muscle group for muscle stimulation.
Tissue temperature was monitored and controlled. A fine wire thermocouple (Mallinckrodt Corp.) was placed close to the fiber-optic probe and sampled muscle tissue. Local temperature was maintained at 37 6 0.5 8C using a proportional temperature controller (Barnant, Barrington IL) and hot-air blower positioned 20 cm from the forelimb.
Spectral acquisition began after animals were instrumented and stable. Continuous spectra were acquired and animals were ventilated with oxygen throughout the remainder of the study, during ischemia and recovery.
Ischemia was induced in the forelimb by pulling a 0.5-in.-wide strap tight, proximal to the optical probe. The strap was held in place with a clamp for the 10-min ischemic period. After a recovery period of 10-15 min, complete deoxygenation of the forelimb was attained with a combination of ischemia and electrical muscle stimulation for 10 min. Pulses were 5 V of 5 ms duration, with a frequency of 2 Hz (model SD9, Grass Technologies). Animals were euthanized with a pentobarbital anesthetic overdose into the ear vein at the end of the experiments.
Optical Spectrometer. A custom-built fiber-optic probe with a 1.75-mm separation between transmitting and receiving fibers was used to assure an average depth of light penetration of 0.4 to 0.5 mm into the muscle. 25 The probe had a concentric design in which optical fibers transmitting light to the sample were arranged in a ring around a central bundle of fibers that brought reflected light from the tissue to the spectrometer. 26 Since the probe was placed directly on the muscle and it had a shallow depth of photon penetration, it is likely that we sampled homogenous muscle tissue even though we measured and analyzed a wide spectral range (600-850 nm).
Illumination from a constant-intensity quartz-tungsten-halogen white light source (model 66881, Oriel Instruments) was passed through a 1.0-in. water filter and an electromechanical shutter (model 76995, Oriel Instruments) before transmission to the optical probe to decrease tissue heating. Constant light intensity was ensured by a photo-feedback system (model 68850, Oriel Instruments). Optical spectra were acquired with a diffraction spectrograph (model 100S, American Holographics) equipped with a 512-pixel photodiode array (model C4350, Hamamatsu) using a 200-ms exposure time. Each pixel spanned 1 nm in the spectrum. Spectral acquisition was gated to acquire data at 2.5-s intervals, and the data were converted to digital form using a 16-bit analog-to-digital converter (model AT-MIO-16X, National Instruments).
Spectral Preprocessing. All calibration set spectra and all test spectra (in vitro and in vivo) were preprocessed by taking second derivatives with respect to wavelength. Using secondderivative spectra eliminates baseline offsets and removes much of the effect of scattering on the spectra. 18 Spectral Analysis by Partial Least Squares. Myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation were determined from each in vitro or in vivo test spectrum by three separate PLS analyses in the wavelength range 600-850 nm, encompassing 250 spectral points. PLS is an extension of linear regression that is useful for extracting information on specific spectral components from complex spectra. 27 The algorithm generates a set of calibration coefficients at each wavelength when calibrated with spectra from solutions with known values of myoglobin saturation, hemoglobin saturation, or cytochrome aa3 oxidation. The dot product of the calibration coefficients that correspond to myoglobin saturation, hemoglobin saturation, or cytochrome aa3 oxidation with a test spectrum determines the unknown saturation or oxidation for that spectrum. When trained this way, the PLS algorithm interprets spectral variations with time as changes in myoglobin saturation, hemoglobin saturation, or cytochrome aa3 oxidation and not as changes in concentration. In the short time span of an experiment, myoglobin and cytochrome aa3 concentrations are not expected to vary, but hemoglobin concentrations can vary greatly with changes in blood volume during reactive hyperemia. Therefore, hemoglobin saturation values measured during hyperemia were not used. The PLS algorithm is described more fully in Refs. 26-28. In vitro calibration set spectra containing the three chromophores and Intralipid were obtained by mathematically adding spectra of solutions acquired at the extremes of saturation or oxidation, 26 . Known values of myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation for each spectrum were used to calibrate PLS. Three separate calibration sets were used to determine the calibration coefficients for myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation. In the myoglobin saturation and cytochrome aa3 oxidation calibration sets of 400 spectra each, both scattering levels and both hemoglobin concentrations were represented to mimic chromophore concentrations and scattering coefficients found in muscle.
Two hemoglobin concentrations were included to make measurements of myoglobin saturation and cytochrome aa3 oxidation less sensitive to changes in total hemoglobin concentration. The hemoglobin saturation calibration set was composed of 400 spectra with both scattering levels. In this calibration set, all spectra had a hemoglobin concentration of 100 lM so that the PLS model would be sensitive to hemoglobin saturation and not to hemoglobin concentration. Two myoglobin concentrations (75 lM and 150 lM) were included in the calibration set to make measurements of hemoglobin saturation less sensitive to the ratio of hemoglobin to myoglobin concentration present in the muscle.
A PLS model was formed from each calibration set by providing the algorithm with the calibration spectra and the known associated values for myoglobin saturation, hemoglobin saturation, or cytochrome aa3 oxidation. In this way, each PLS model was sensitive to a single variable, and spectral variations associated with the other chromophores were treated as uncorrelated noise. The optimal number of factors for each chromophore was determined by a PRESS (prediction error sum of squares) analysis. 27 The calibration coefficient vectors for myoglobin, hemoglobin, and cytochrome oxidase each encompassed seven factors.
In Vitro Test Set. A test set of 300 in vitro spectra was formed to evaluate the PLS models. Pure component spectra shown in Fig. 2A 
where x ¼ 2prn m k À1 . The refractive index of tissue, n m , is 1.35 and r is the mean radius of the scattering centers within the tissue. Torricelli et al. used time-resolved spectroscopy to measure l 0 s ðkÞ in the human arm, forehead, and abdomen, fit their data to Eq. 2, and then solved for parameters a and b. 29 We used the a, b, and r parameters they determined for the human arm to estimate l 0 s ðkÞ from 600-850 nm. The l a spectra and the reduced scattering coefficients were combined to produce tissue attenuation spectra using the steady-state diffusion equation. 30 From a solution to the diffusion equation for a point source, tissue attenuation can be defined as:
where r ¼ ðl a cÞ 1=2 =c, c represents the speed of light in tissue, c 2 is the diffusion coefficient given by c=ð3ðl a þ l 0 s ÞÞ, and q is the distance between the source and detector.
Endpoint Scaling of Partial Least Squares Values. The relative saturation and oxidation values from the PLS analyses of the in vivo spectra were scaled by determining two points of known saturations or oxidations in each animal. 18 The maximum value for myoglobin saturation obtained during reactive hyperemia after the release of the ischemic cuff were assumed to be 100%. Hemoglobin was assumed to be 100% saturated and cytochrome aa3 was assumed to be completely oxidized at rest while the animal breathed oxygen. Myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation were all assumed to be completely desaturated or reduced at the end of the 10-min period of ischemia combined with muscle stimulation. This assumption is supported by the finding that all the variables approached an asymptote toward the end of this period. All PLS values from a single animal were scaled between these maximum and minimum endpoint values, allowing PLS results from different animals to be compared. It should be noted that the assumptions of 0% and 100% saturations and oxidations as described have not been validated by independent measurements. Variations in the endpoint values from 0% and 100% will cause corresponding errors in scaled PLS values.
Intracellular cytoplasmic oxygen tension is related to myoglobin saturation by the Hill equation:
where P 50 for myoglobin at 37 8C is 2.39 Torr 31 and Mb sat is myoglobin saturation.
Statistical Tests for Match Between in Vitro Calibration Set and in Vivo Muscle Spectra. The accuracy of PLS values for myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation from in vivo spectra depends on how similar the in vitro calibration set spectra are to the in vivo spectra. Two statistical tests were used to demonstrate that the in vitro calibration set spectra resemble in vivo spectra from the rabbit limb: calculation of Mahalanobis distances and the residual ratio test.
To calculate Mahalanobis distances, a principal component analysis (PCA) was carried out on the second-derivative calibration set spectra. Using the first n principal components, scores were determined for each second-derivative in vivo spectrum. A Mahalanobis distance is defined as the ndimensional geometric distance between a spectrum's scores and the mean of scores from the calibration set spectra, where n is the number of principal components used. The value of n was chosen as the number of factors used in the PLS model. Because the scores of an in vivo spectrum were calculated from the principal components derived from the calibration set, the Mahalanobis distance quantitatively represents the difference in spectral character between this spectrum and the spectra in the calibration set. Each Mahalanobis distance was associated with a probability value according to the chi-squared distribution. Spectra with a probability value between 1.0 and 0.05 were classified as ''members'' of the calibration set, and those with probability values less than 0.05 were labeled as ''outliers''.
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Another test for the similarity between calibration set spectra and in vivo spectra is the residual ratio test. Both the in vitro calibration set spectra and the in vivo spectra were reconstructed from the first n loadings obtained from principal component analysis of the calibration set. The residual for each reconstructed spectrum, both in vitro and in vivo, was determined as the difference at each wavelength between the original and reconstructed spectrum. The residual ratio for an in vivo spectrum is the ratio of the sum of squares of residuals for that spectrum to the mean sum of squares of residuals in all of the calibration set spectra. A residual ratio of greater than 3-4 for a given in vivo spectrum indicates that the PLS model is not relevant for that spectrum. 33 Statistical Analyses. All spectral analysis was done in Matlab (The MathWorks, Inc.), while all statistics and curve fits were done using Origin (Originlab Corp.).
RESULTS AND DISCUSSION
The feasibility of measuring myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation from a single spectrum was tested in vitro and then was evaluated in the rabbit forelimb. Figure 2A shows component spectra from in vitro solutions of the three major chromophores in the spectral range 600-850 nm. In the NIR, Mb and Hb absorbances at ;760 nm are the most distinct spectral features that contribute to determining myoglobin and hemoglobin saturations. In the second derivative (Fig. 2B) , the absorbances of Mb and Hb become narrower and better separated from each other when compared to the raw spectra. The ;4-nm shift between Mb and Hb allows myoglobin and hemoglobin saturations to be independently determined when a spectrum of wavelengths is measured and analyzed. 15, 17, 19 The second derivative also helps to distinguish oxidized and reduced heme aþa3 in cytochrome oxidase spectra.
Unknown optical path lengths in tissue have hampered continuous-wave optical measurements of tissue chromophores, especially in cases in which only a few wavelengths are measured. For example, changes in blood volume can cause 2-wavelength cytochrome redox measurements in the brain to vary without an actual change in cytochrome redox. 34 Our approach includes removing much of the effect of scattering on the spectra by using second-derivative spectra. 18 Also, when various scattering coefficients and hemoglobin concentrations are included in the calibration set spectra, PLS calibration vectors become relatively insensitive to them. 26 When the 300 in vitro test set spectra were applied to each of the three calibration coefficient vectors, good accuracy was achieved for all measured variables (Fig. 3) . The standard errors (SE) of the predicted values were 5.9%, 7.4%, and 12.2% for myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation, respectively.
Pair-wise plotting of myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation values obtained from each test set spectrum shows that there is little cross-talk between the measurements in vitro (Fig. 4) . Data points represent the same test set spectra shown in Fig. 3 where myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation were varied randomly from each other. Despite their very similar absorbance spectra (Fig. 2) , myoglobin and hemoglobin saturation measurements were not correlated. Myoglobin and hemoglobin saturations can be determined independently from the same spectrum in vitro (Figs. 3A and 3B) with modest cross-talk and an R 2 value of 0.169 (Fig. 4A) . The correlations between cytochrome aa3 oxidation and both FIG. 3 . In vitro measurements of (A) myoglobin saturation, (B) hemoglobin saturation, and (C) cytochrome aa3 oxidation. Measurements in all panels were determined from the same test set spectra that were derived from a steady-state diffusion equation. Good accuracy was obtained in all three measurements. Standard errors (SE) were 5.9%, 7.4%, and 12.2% for myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation, respectively. Correlation coefficients (R myoglobin and hemoglobin saturations were also poor in vitro (Figs. 4B and 4C, R 2 ¼ 0.052 and 0.208, respectively). Mahalanobis distances were calculated for all 522 in vivo spectra from the two animals using the first seven principal components of the calibration set. None of the spectra were classified as outliers when compared to the calibration set using the chi-squared distribution. Residual ratios were also calculated for the 522 in vivo spectra from the first seven principal components of the calibration set. All of the spectra had residual ratios that were less than 3, indicating that the PLS model based on the in vitro calibration set is appropriate for these in vivo spectra.
Because chromophore concentrations and scattering coefficients are unknown in vivo, and are likely to be different from those in the in vitro calibration set spectra, PLS only provides relative myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation values. In each animal, PLS values obtained during the study were scaled with PLS values measured at two known end-point physiological states.
Deoxygenated and reduced conditions were produced physiologically by a 10-min period of ischemia combined with muscle stimulation. Values for cytochrome oxidation, myoglobin saturation, and hemoglobin saturation were assumed to be 0% at the end of this period. Myoglobin saturation was ;9% lower at the end of 10 min of combined ischemia and muscle stimulation than with 10 min of ischemia alone. Similarly, hemoglobin saturations were ;10% lower and cytochrome aa3 oxidations were ;18% lower after ischemia and stimulation when compared to values measured after ischemia alone. If myoglobin saturations and cytochrome oxidations were actually greater than 0% at the end of ischemia combined with muscle stimulation, then the scaled PLS values are underestimates.
The upper end point for myoglobin saturation was obtained during reactive hyperemia upon release of the tourniquet. The upper end point for cytochrome aa3 oxidation was obtained during hyperoxia (the rabbit breathed 100% oxygen) in resting muscle. If myoglobin saturations and cytochrome oxidations were actually less than 100% at these two physiological states, the scaled PLS values are overestimates.
Hemoglobin saturation was assumed to be 100% while the animal was at rest and breathing oxygen. PLS values for hemoglobin saturation during reactive hyperemia, while higher than those measured at rest, were not used since the PLS analysis assumes that total hemoglobin concentration is constant and that spectral changes are due to changes in hemoglobin saturation. In hyperoxia in resting muscle, hemoglobin saturation throughout the vascular space is very high. In the isolated dog gastrocnemius muscle at rest, arterial and venous oxygen tensions were 509 and 285 Torr, respectively, during breathing with 100% oxygen, 35 much higher than the P 50 of 30 Torr in canine blood at 37 8C. 36 The corresponding arterial and venous hemoglobin saturations were 99.97% and 99.85%, respectively. If hemoglobin saturation was less than 100% in muscles at rest while the animal breathed 100% oxygen, scaled measurements of hemoglobin saturation will be overestimates.
Ischemia in the rabbit forelimb caused a decline in all three variables and demonstrated in vivo that myoglobin saturation, hemoglobin saturation, and cytochrome aa3 oxidation can be separately determined from each spectrum (Fig. 5A) . Hemoglobin saturation declined ;5 s after the onset of ischemia. Myoglobin saturation remained at baseline levels for ;7.5 s before declining, and cytochrome aa3 oxidation remained constant for ;17.5 s before beginning to decrease. The temporal separation between the decreases in the measurements is supportive evidence that separate measures of the three chromophores can be made in vivo. These results are consistent with other in vivo studies. Hemoglobin desaturated before cytochrome oxidase began to reduce during anoxia in the piglet brain 13 and in the rat brain with hypoxia. 9 NMR measurements showed that myoglobin desaturation lagged hemoglobin desaturation during ischemia in the human gastrocnemius. 5 A preliminary view of the in vivo oxygen dependence of myoglobin saturation and cytochrome aa3 oxidation is shown in Fig. 5B . Spectra were acquired during an ischemic bout in each of two rabbits, and myoglobin saturation and cytochrome FIG. 5 . (A) In vivo measurements of hemoglobin saturation, myoglobin saturation, and cytochrome aa3 oxidation during progressive ischemia in the forelimb of one rabbit (onset of the tourniquet is at Time ¼ 0). Measurements in three anatomical compartments made from each spectrum are separable. Hemoglobin desaturated first, followed by myoglobin, followed by cytochrome aa3 reduction. Temporal resolution is ;2.5 s. (B) Oxygen dependence of cytochrome aa3 oxidation and myoglobin saturation in blood-perfused skeletal muscle subjected to ischemia as in (A) in two animals. Intracellular PO 2 was determined from measured myoglobin saturations and the previously determined myoglobin oxygen dissociation curve. 31 The curves show that cytochrome aa3 is more sensitive to oxygen than is myoglobin in vivo. The paired myoglobin saturations and cytochrome aa3 oxidations at each value of intracellular PO 2 arose from the same spectra and emphasize the good separability of the measurements. The curve through the cytochrome aa3 data is a fit to an asymptotic exponential of the form y ¼ a À bc x . The curve through myoglobin saturations is the Hill equation (Eq. 4) using a previously determined myoglobin P 50 of 2.39 Torr at 37 8C. 31 Hemoglobin saturation is not shown because it is outside muscle in a separate compartment, the vascular space.
aa3 oxidation were determined from each spectrum. Intracellular PO 2 values were calculated from these myoglobin saturations using Eq. 4. Myoglobin saturations and cytochrome aa3 oxidations from the two animals were then combined and binned along the intracellular PO 2 axis. The line through the cytochrome aa3 oxidation data is a fit to an asymptotic exponential of the form y ¼ a À bc x , while the line through myoglobin saturations is the Hill equation (Eq. 4).
Cytochrome aa3 oxidation has been measured by optical spectroscopy in hemoglobin-free skeletal muscle 7 and myocardium 8 where cytochrome oxidase oxidation was equal to myoglobin saturation at all values of perfusate oxygen tension as it decreased from fully oxygenated to fully deoxygenated. In contrast, in vitro measurements of the P 50 of cytochrome aa3 oxidation (oxygen tension required for half-maximal reduction of cytochrome aa3) are lower than the P 50 of myoglobin. 37 The simultaneously determined in vivo measurements of cytochrome aa3 oxidation and myoglobin saturation in bloodperfused muscle in Fig. 5B indicate that cytochrome aa3 in vivo is more sensitive to oxygen than myoglobin, in agreement with in vitro findings.
The present method is limited by the need to obtain physiological end points and by the unvalidated values of 0% and 100% saturation and oxidation during end point states. Also, since the optical probe was placed directly on the muscle, interference from skin and lipid has not been addressed. However, the present paper presents a proof of principle in two animals that PLS analysis of optical spectra can yield separable and simultaneous in vivo measurements of oxygenation in the local vasculature (hemoglobin), inside myocytes (myoglobin), and within the mitochondrial compartment (cytochrome aa3). The ability to track oxygen along its pathway from the vasculature to the mitochondria will be useful in improving understanding of oxygen transport and utilization in tissues.
